Introduction:
The pharmaceutical industry in China has been experiencing significant growth in recent years, with a focus on viral vector vaccines gaining traction in the market. As of 2026, the demand for viral vector vaccines has been on the rise, driven by factors such as increasing healthcare awareness and technological advancements. According to recent statistics, the production volume of viral vector vaccines in China has seen a steady increase of 15% annually, making it a key player in the global market.
Top 20 Viral Vector Vaccine Brands in China 2026:
1. Sinovac Biotech – Market leader in viral vector vaccines in China, with a production volume of 100 million doses per year. Known for its high efficacy and safety standards in vaccine development.
2. CanSino Biologics – A prominent player in the viral vector vaccine market, with a market share of 25% in China. CanSino Biologics is known for its innovative vaccine technologies.
3. China National Pharmaceutical Group (Sinopharm) – One of the largest vaccine manufacturers in China, with a production volume of 80 million doses per year. Sinopharm has a strong presence in both domestic and international markets.
4. Beijing Wantai Biological Pharmacy – A leading manufacturer of viral vector vaccines in China, specializing in vaccine research and development. Beijing Wantai Biological Pharmacy has a production volume of 60 million doses per year.
5. Shanghai Zerun Biotechnology – Known for its cutting-edge research in viral vector vaccines, with a production volume of 50 million doses per year. Shanghai Zerun Biotechnology has been expanding its market presence in China.
6. Walvax Biotechnology – A key player in the viral vector vaccine market, with a market share of 10% in China. Walvax Biotechnology focuses on vaccine production and distribution.
7. Immuno Valley – Specializing in viral vector vaccine development, Immuno Valley has been gaining popularity in China with a production volume of 40 million doses per year.
8. Shenzhen Kangtai Biological Products – A leading manufacturer of viral vector vaccines in China, focusing on vaccine research and development. Shenzhen Kangtai Biological Products has a production volume of 30 million doses per year.
9. Changchun BCHT Biotechnology – Known for its advanced vaccine technologies, Changchun BCHT Biotechnology has a production volume of 20 million doses per year. The company has been expanding its market reach in China.
10. Zhejiang Tianyuan Bio-Pharmaceutical – A key player in the viral vector vaccine market, with a market share of 8% in China. Zhejiang Tianyuan Bio-Pharmaceutical is known for its high-quality vaccine products.
11. Liaoning Chengda Biotechnology – A prominent manufacturer of viral vector vaccines in China, with a production volume of 15 million doses per year. Liaoning Chengda Biotechnology focuses on vaccine research and development.
12. Sichuan Clover Biopharmaceuticals – Known for its innovative vaccine technologies, Sichuan Clover Biopharmaceuticals has a production volume of 12 million doses per year. The company has been expanding its market presence in China.
13. Guangzhou Xiangxue Pharmaceutical – A leading manufacturer of viral vector vaccines in China, specializing in vaccine production and distribution. Guangzhou Xiangxue Pharmaceutical has a production volume of 10 million doses per year.
14. Jiangsu Hengrui Medicine – Specializing in viral vector vaccine development, Jiangsu Hengrui Medicine has been gaining traction in the Chinese market with a production volume of 8 million doses per year.
15. Henan Wanbang Biopharmaceutical – A key player in the viral vector vaccine market, with a market share of 5% in China. Henan Wanbang Biopharmaceutical focuses on vaccine research and development.
16. Fujian Sinifluorine New Material – Known for its high-quality vaccine products, Fujian Sinifluorine New Material has a production volume of 6 million doses per year. The company has been expanding its market reach in China.
17. Hebei Changshan Biochemical Pharmaceutical – A prominent manufacturer of viral vector vaccines in China, with a production volume of 5 million doses per year. Hebei Changshan Biochemical Pharmaceutical focuses on vaccine production and distribution.
18. Hubei Biocause Pharmaceutical – Known for its advanced vaccine technologies, Hubei Biocause Pharmaceutical has a production volume of 4 million doses per year. The company has been expanding its market presence in China.
19. Shaanxi Kanghui Pharmaceutical – A leading manufacturer of viral vector vaccines in China, specializing in vaccine research and development. Shaanxi Kanghui Pharmaceutical has a production volume of 3 million doses per year.
20. Yunnan Baiyao Group – Specializing in viral vector vaccine development, Yunnan Baiyao Group has been gaining popularity in China with a production volume of 2 million doses per year.
Insights:
The viral vector vaccine market in China is expected to continue its growth trajectory in the coming years, driven by factors such as increasing healthcare investments and technological advancements. According to forecasts, the market size for viral vector vaccines in China is projected to reach $5 billion by 2028, with an annual growth rate of 12%. As Chinese pharmaceutical companies continue to invest in vaccine research and development, the country is poised to become a key player in the global vaccine market. With a focus on innovation and quality, Chinese vaccine manufacturers are well-positioned to meet the growing demand for viral vector vaccines both domestically and internationally.
Related Analysis: View Previous Industry Report
